Nurix Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nurix Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Nurix Therapeutics, Inc. Current Ratio for the quarter ending August 31, 2024 was 425 %, a 1.69% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 425 -7.32 -1.69% Aug 31, 2024
Q2 2024 399 -55.5 -12.2% May 31, 2024
Q1 2024 358 -102 -22.1% Feb 29, 2024
Q4 2023 400 -55.5 -12.2% Nov 30, 2023
Q3 2023 433 -27.4 -5.96% Aug 31, 2023
Q2 2023 455 -37 -7.52% May 31, 2023
Q1 2023 460 -126 -21.5% Feb 28, 2023
Q4 2022 455 -195 -30% Nov 30, 2022
Q3 2022 460 -258 -35.9% Aug 31, 2022
Q2 2022 492 -268 -35.3% May 31, 2022
Q1 2022 586 Feb 28, 2022
Q4 2021 650 Nov 30, 2021
Q3 2021 718 Aug 31, 2021
Q2 2021 759 May 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.